AU4045193A - Control and/or prevention of binding of NF-KB/rel/dorsal (NRD) family proteins to DNA - Google Patents

Control and/or prevention of binding of NF-KB/rel/dorsal (NRD) family proteins to DNA

Info

Publication number
AU4045193A
AU4045193A AU40451/93A AU4045193A AU4045193A AU 4045193 A AU4045193 A AU 4045193A AU 40451/93 A AU40451/93 A AU 40451/93A AU 4045193 A AU4045193 A AU 4045193A AU 4045193 A AU4045193 A AU 4045193A
Authority
AU
Australia
Prior art keywords
nrd
rel
dorsal
dna
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40451/93A
Inventor
Warren J. Leonard
Michel B Toledano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU4045193A publication Critical patent/AU4045193A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
AU40451/93A 1992-04-06 1993-04-01 Control and/or prevention of binding of NF-KB/rel/dorsal (NRD) family proteins to DNA Abandoned AU4045193A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US862987 1986-05-14
US86298792A 1992-04-06 1992-04-06

Publications (1)

Publication Number Publication Date
AU4045193A true AU4045193A (en) 1993-11-08

Family

ID=25339941

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40451/93A Abandoned AU4045193A (en) 1992-04-06 1993-04-01 Control and/or prevention of binding of NF-KB/rel/dorsal (NRD) family proteins to DNA

Country Status (2)

Country Link
AU (1) AU4045193A (en)
WO (1) WO1993020219A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7429646B1 (en) 1995-06-05 2008-09-30 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor-like 2
US7427492B1 (en) 1995-06-05 2008-09-23 Human Genome Sciences, Inc. Polynucleotides encoding human tumor necrosis factor receptor-like2
EP0854921A1 (en) * 1995-09-26 1998-07-29 Novartis AG GENE THERAPY WITH MODIFIED p65 PROTEINS
CA2245503A1 (en) * 1996-02-14 1997-08-21 Novartis Ag Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions

Also Published As

Publication number Publication date
WO1993020219A1 (en) 1993-10-14

Similar Documents

Publication Publication Date Title
IL123873A0 (en) Isolated heregulin protein a composition containing it and methods of obtaining it
AU5136093A (en) Peptide antagonists of sh2 binding and therapeutic uses thereof
IL117274A (en) Method of making heteromultimeric polypeptides a heteromultimer and a composition containing it
HU9303282D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
EP0785276A4 (en) Modification of peptide and protein
PL314003A1 (en) Combination of bisulphonates and substances enhancing secretion of growth hormone
AU3673895A (en) Peptide mixture and products thereof
AU6402694A (en) Methods and materials relating to the functional domains of dna binding proteins
AU2514592A (en) Methods and compositions for modulating g protein action
AU5716696A (en) Decorin binding protein compositions and methods of use
HU9303283D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
GB9310472D0 (en) Phenylalanine-free protein and dna coding thereof
AU1193092A (en) Granulated pharmaceutical composition and method of obtaining it
IL118221A0 (en) Substituted cephalosporins and pharmaceutical compositions containing them
AU6911194A (en) Methods and compositions relating to sterol regulatory element binding proteins
IL113484A0 (en) Viral proteins pharmaceutical compositions containing them their preparation and use
AU1406388A (en) Method of purifying polydextrose and composition containing same
AU1097192A (en) Treatment of particulate material
AU3329593A (en) Separation of phytate and manganese from plant protein and dietary fiber using alumina
IL103462A0 (en) Preparation of recombinant borrelia proteins
AU4045193A (en) Control and/or prevention of binding of NF-KB/rel/dorsal (NRD) family proteins to DNA
AU5592294A (en) Induction of dwarfing and early flowering using group 3 lea proteins
AU7804591A (en) Reduction and inhibition of ETU content in alkylenebisdithiocarbamates
AU6158696A (en) Di- and tri-aminoguanidines and their use to inhibit the advanced glycosylation of proteins
AU1996388A (en) Proteins and protein compositions and their use